Grab Twelve South's Foldable Wireless Charger for iPhone and Apple Watch at a $59 Discount
That top-line discount applies to the black version. Some other color options are discounted as well, though the price may vary. It's not clear how long the discounts will last, so you'll want to hurry.
The charger lets you wirelessly charge a iPhone and Apple Watch from a single AC outlet. You can also charge your AirPods when your phone is done. Since this is a Qi2 charger, you'll get a full 15 watts of wireless charging for compatible devices, including the best iPhones.
Hey, did you know? CNET Deals texts are free, easy and save you money.
When you're not using the Butterfly SE wireless charger, it folds up easily so it can be slid into a pocket, bag or luggage without taking up too much space. It really is the perfect partner for people who prefer to travel light.
Unfortunately, this charger doesn't come with an AC adapter in the box, so you'll need to provide your own. Make sure it's rated for 20 watts or more. If you need to buy one, Apple's 20-watt USB-C charger is just $13 right now.
Why this deal matters
We all carry multiple devices around with us these days. Anything that can make charging them more convenient is a win in our books, especially when you're traveling. This charger takes up little space when it isn't being used and charges quickly when it is.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Medpace (MEDP) Q2 Earnings Report Preview: What To Look For
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be reporting results this Monday after market hours. Here's what to expect. Medpace beat analysts' revenue expectations by 6% last quarter, reporting revenues of $558.6 million, up 9.3% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts' organic revenue estimates and an impressive beat of analysts' EPS estimates. Is Medpace a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Medpace's revenue to grow 2.6% year on year to $542 million, slowing from the 14.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $3.00 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Medpace has missed Wall Street's revenue estimates five times over the last two years. With Medpace being the first among its peers to report earnings this season, we don't have anywhere else to look to get a hint at how this quarter will unravel for life sciences tools & services stocks. However, the whole sector has been hit hard over the last month as stocks in Medpace's peer group are down 2.5% on average. Medpace's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $301.61 (compared to the current share price of $311.86). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
Earnings To Watch: W. R. Berkley (WRB) Reports Q2 Results Tomorrow
Property casualty insurer W. R. Berkley (NYSE:WRB) will be announcing earnings results this Monday after market close. Here's what to look for. W. R. Berkley met analysts' revenue expectations last quarter, reporting revenues of $3.55 billion, up 8.9% year on year. It was a slower quarter for the company, with a significant miss of analysts' book value per share estimates and EPS in line with analysts' estimates. Is W. R. Berkley a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting W. R. Berkley's revenue to grow 9.7% year on year to $3.63 billion, in line with the 10.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.02 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. W. R. Berkley has missed Wall Street's revenue estimates three times over the last two years. Looking at W. R. Berkley's peers in the insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Progressive delivered year-on-year revenue growth of 21.3%, beating analysts' expectations by 1.4%, and Travelers reported revenues up 7.4%, in line with consensus estimates. Progressive traded up 2.2% following the results while Travelers was also up 5.5%. Read our full analysis of Progressive's results here and Travelers's results here. Investors in the insurance segment have had fairly steady hands going into earnings, with share prices down 1.7% on average over the last month. W. R. Berkley is down 6.8% during the same time and is heading into earnings with an average analyst price target of $71.50 (compared to the current share price of $68.75). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
21 minutes ago
- Yahoo
WNBA commissioner confident CBA will be signed by deadline despite player concerns
INDIANAPOLIS — WNBA commissioner Cathy Engelbert said Saturday she is confident that the league and the WNBPA can agree to a new Collective Bargaining Agreement ahead of the league's Oct. 31 deadline. The league and the WNBPA met on Thursday afternoon for multiple hours, with the meeting marking the first in-person bargaining session that players attended since December. Engelbert characterized the talks as 'constructive' and said she believed the league and players would agree to a new CBA that is 'transformational for the players, teams, owners and the future of our league.' 'I have confidence we can get something done by October, but I'm not going to put an exact date on it,' she said. 'We've got some room to continue negotiations if we're close at that point.' As Engelbert spoke, players from both teams took the floor wearing shirts that read 'Pay Us What You Owe Us.' Salary structure and revenue sharing have become a hot topic in the ongoing talks, as players expressed frustration at a recent league counterproposal. Many players, however, gave a different characterization of Thursday's meeting than Engelbert. New York Liberty star Breanna Stewart, who is a vice president of the WNBPA, called it 'a wasted opportunity' and said there was 'fluff to start' the meeting. Minnesota Lynx star Napheesa Collier, also a vice president, said she hopes the league 'comes back quickly' so that dialogue can continue. Seattle Storm star Nneka Ogwumike, who is the WNBPA president, said that they were 'hoping perhaps more would be yielded given the engagement.' 'We have a long way to go. We're gonna use this weekend to show our value and our worth and continue to be united because we do deserve more,' said Los Angeles Sparks guard Kelsey Plum, who is the first vice president of the WNBPA. A record number of players attended Thursday's meeting between the WNBA and WNBPA, with further negotiations coming executive director Terri Jackson said she felt encouraged by player participation, but did not give details on whether she considered the meeting successful. 'Negotiations are hard. They have hard conversations. … That's what today was, no different from any other negotiation,' she said. Jackson said another meeting is scheduled 'soon,' though she did not specify a date or location. Engelbert said that the league wants to 'significantly increase' player salaries and other benefits, but said that it is important to do so by 'balancing with our owners (and) their ability to have a path to profitability. 'I really respect the players. We're listening. They're listening to our owners. We're kind of in the middle as the league trying to make sure we're setting this league up for success for decades. That's the goal, to have a fair CBA for all.' The current CBA began in January 2020, and while it sparked several significant shifts in the league, such as groundbreaking maternity benefits and a notable jump in maximum player salaries, much has changed around the WNBA since. Just two weeks ago, the WNBA announced three expansion teams in Cleveland, Detroit and Philadelphia, which are set to debut in 2028, 2029 and 2030, respectively. All three will enter the league at a record $250 million expansion fee. A new 11-year, $2.2 billion TV deal will also go into effect next season. Engelbert said national TV viewership is up 23 percent, attendance is up 26 percent and merchandise sales up 40 percent. Here are other things that came out of Engelbert's availability: Engelbert said the WNBA is thinking about expanding its future scheduling footprint as well as the number of games played in upcoming seasons. While the number of games in a season will have to be part of collective bargaining with the WNBPA, Engelbert said the league may have to extend into early November 'in the near-term.' The 2026 FIBA World Cup will run from Sept. 4-13, 2026, and the league may need a break to accommodate players who want to play. Ogwumike said during Thursday's CBA media availability that the league did pose ideas regarding extending the season. WNBA teams are playing 44 games this season, the most they have ever had in a season and the current maximum under the CBA. It seems as if there will be future changes to WNBA All-Star Friday nights. Engelbert said the league is looking at possible revisions to the festivities, which this year included only the Skills Challenge and 3-Point Contest. 'We'll definitely be looking at different ideas, different formats beyond the skills and 3-point (contest),' Engelbert said. 'I got a lot of fans asking me today at WNBA Live, 'We want more W this weekend.' We're going to look at that and hopefully deliver something in the future on that.' Caitlin Clark, Rhyne Howard and Satou Sabally were all unable to participate in Saturday's All-Star Game due to injury, and many around the league have wondered whether there are more injuries this season than normal. However, Engelbert said, 'I think the rate of injury is about similar to last year.' Throughout the first half of the season, players and coaches from across the league have routinely criticized WNBA officiating, often describing it as 'inconsistent.' Engelbert said the league hears the concerns from its key stakeholders, and that 'we're working hard to make sure that we put the best product on the court, and our officiating follows that.' She added: 'I realize consistency is the name of the game and I think it's something we definitely need to look at and evaluate.' This article originally appeared in The Athletic. WNBA 2025 The Athletic Media Company
